BIODESIX INC·4

Feb 23, 8:22 PM ET

Cowie Robin Harper 4

Research Summary

AI-generated summary

Updated

Biodesix (BDSX) CFO Robin Harper Cowie Sells 535 Shares to Cover Taxes

What Happened

  • Robin Harper Cowie, Chief Financial Officer, reported the conversion/vesting of 1,469 restricted stock units (RSUs) on Feb 20, 2026. Following the vesting, 535 shares were sold in an open-market transaction on Feb 23, 2026 at a weighted average price of $12.78, generating approximately $6,835. The filing shows the RSU conversion/derivative transaction and the subsequent sale to cover tax withholding.

Key Details

  • Transaction dates: RSU conversion/vesting recorded 2026-02-20; open-market sale recorded 2026-02-23.
  • Sale: 535 shares sold at a weighted average price of $12.78; total proceeds reported ~$6,835.
  • Derivative/vesting: 1,469 RSUs converted to common stock (reported as an M-code exercise/conversion).
  • Tax withholding: Shares were sold/withheld to cover taxes upon RSU vesting (automatic sell-to-cover). The sale price reported is a weighted average; prices for the broker’s multiple trades ranged $12.58–$13.16 (footnote).
  • Reverse split: All share amounts were adjusted for the one-for-twenty reverse split effective Sept 15, 2025.
  • Shares owned after transaction: Not specified in the filing.
  • Timeliness: Form 4 was filed on Feb 23, 2026 for a Feb 20, 2026 vesting/sale — appears timely (filed within the Form 4 reporting window).

Context

  • These were RSU vesting and related sell-to-cover tax transactions (routine administrative actions), not an independent open-market investment decision. For derivative entries: converting RSUs into shares is common and, when paired with sell-to-cover, typically reflects tax-withholding rather than a directional bet on the stock.